North America Androgenetic Alopecia Market Size & Outlook
Global Market
Related Markets
North America androgenetic alopecia market highlights
- The North America androgenetic alopecia market generated a revenue of USD 1,017.0 million in 2023.
- The market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating treatment in 2023.
- Devices is the most lucrative treatment segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 1,017.0 million |
| Market revenue in 2030 | USD 1,598.6 million |
| Growth rate | 6.7% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals, Devices |
| Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
Other key industry trends
- In terms of revenue, North America region accounted for 37.4% of the global androgenetic alopecia market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,493.9 million by 2030.
North America dominated the global Androgenetic Alopecia (AGA) market in 2023. Growth in the region is driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure.
Furthermore, the increasing investments in Research & Development (R&D) of alopecia treatment and developed healthcare facilities are significantly contributing to market growth. For instance, in March 2022, Kintor Pharmaceutical Limited initiated a phase 2 clinical trial of KX-826 (Pyrilutamide) by dosing the first male AGA patient in the U.S.
The North American Hair Research Society and the American Hair Loss Association conduct research on treating alopecia by involving scientists from different disciplines. They also periodically conduct meetings & programs to discuss and raise awareness about hair loss & associated treatments.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Androgenetic Alopecia Market Scope
Androgenetic Alopecia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Amgen Inc | View profile | 26,700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | www.amgen.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Cipla Ltd DR | View profile | 38,955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | www.cipla.com |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | aurobindo.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | www.sunpharma.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | www.drreddys.com/ |
| Cardiff Lexington Corp | View profile | 13 | 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV, United States, 89169 | www.cardifflexington.com |
| Theradome | View profile | 1-10 | Pleasanton, California, United States, North America | www.theradome.com/ |
| Curallux | View profile | 101-250 | Miami, Florida, United States, North America | curallux.com/ |
North America Androgenetic Alopecia Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Androgenetic Alopecia Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.09% in 2023.
Horizon Databook has segmented the North America androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the global Androgenetic Alopecia (AGA) market in 2023. Growth in the region is driven by a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improvements in healthcare infrastructure.
Furthermore, the increasing investments in Research & Development (R&D) of alopecia treatment and developed healthcare facilities are significantly contributing to market growth. For instance, in March 2022, Kintor Pharmaceutical Limited initiated a phase 2 clinical trial of KX-826 (Pyrilutamide) by dosing the first male AGA patient in the U.S.
The North American Hair Research Society and the American Hair Loss Association conduct research on treating alopecia by involving scientists from different disciplines. They also periodically conduct meetings & programs to discuss and raise awareness about hair loss & associated treatments.
- North America Androgenetic Alopecia Market Treatment Outlook (Revenue, USD MIllion , 2018-2030)
- Pharmaceuticals
- Devices
- North America Androgenetic Alopecia Market End-use Outlook (Revenue, USD MIllion , 2018-2030)
- Homecare Settings
- Dermatology Clinics
- North America Androgenetic Alopecia Market Sales Channel Outlook (Revenue, USD MIllion , 2018-2030)
- Prescriptions
- OTC
- North America Androgenetic Alopecia Market Gender Outlook (Revenue, USD MIllion , 2018-2030)
- Male
- Female
Reasons to subscribe to Androgenetic Alopecia Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Androgenetic Alopecia Market Outlook databook
- Our clientele includes a mix of Androgenetic Alopecia Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Androgenetic Alopecia Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Androgenetic Alopecia Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
North America Androgenetic Alopecia Market, 2018-2030 (US$M)
North America androgenetic alopecia market statistics, by treatment, 2018-2030 (US$M)
